Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 12140613)

Published in J Hepatobiliary Pancreat Surg on January 01, 2002


Luis Muñoz1, Sasan Roayaie, Daniel Maman, Thomas Fishbein, Patricia Sheiner, Sukru Emre, Charles Miller, Myron E Schwartz

Author Affiliations

1: The Mount Sinai School of Medicine, Recanati / Miller Transplantation Institute, New York, NY, USA.

Articles citing this

Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99

Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) (2005) 1.37

Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol (2012) 0.97

Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92

Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) (2013) 0.89

Staging of extrahepatic cholangiocarcinoma. Eur Radiol (2008) 0.89

Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88

Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis (2006) 0.85

Assessment of hilar and extrahepatic bile duct cancer using multidetector CT: value of adding multiplanar reformations to standard axial images. Eur Radiol (2007) 0.83

Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB (Oxford) (2013) 0.82

Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients. Med Sci Monit (2015) 0.77

Combined portal vein resection for hilar cholangiocarcinoma. Int J Clin Exp Med (2015) 0.75

Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford) (2008) 0.75

Articles by these authors

Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93

The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35

Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42

Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39

Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32

2003 report of the intestine transplant registry: a new era has dawned. Ann Surg (2005) 2.27

Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14

Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A (2009) 2.08

Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl (2015) 2.03

Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services. Pediatr Transplant (2007) 1.95

Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol (2007) 1.95

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90

Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl (2008) 1.75

Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70

Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl (2007) 1.64

Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Liver Transpl (2010) 1.62

Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Liver Transpl (2008) 1.61

Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology (2005) 1.60

Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation (2004) 1.57

Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg (2015) 1.53

Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival. Anesth Analg (2014) 1.52

National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004). Liver Transpl (2006) 1.50

Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant (2005) 1.50

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl (2015) 1.49

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49

Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience. Liver Transpl (2005) 1.48

Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl (2013) 1.47

Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46

Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46

Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B. Liver Transpl (2009) 1.46

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl (2002) 1.45

Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics (2004) 1.44

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology (2004) 1.41

Authors' Submission Toolkit: a practical guide to getting your research published. Curr Med Res Opin (2010) 1.39

Impact of surveillance stool culture guided selection of antibiotics in the management of pediatric small bowel transplant recipients. Pediatr Transplant (2006) 1.39

Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl (2013) 1.39

Effect of small donor weight and donor-recipient weight ratio on the outcome of liver transplantation in children. Pediatr Transplant (2015) 1.38

Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res (2005) 1.37

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36

Anatomic variations in right liver living donors. J Am Coll Surg (2004) 1.33

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer (2009) 1.28

Observing terrestrial ecosystems and the carbon cycle from space. Glob Chang Biol (2015) 1.26

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26

Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl (2002) 1.22

Toxic waste disposal in Escherichia coli. J Bacteriol (2002) 1.17

Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. Ann Surg (2015) 1.17

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17

Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15

Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant (2006) 1.13

Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings. Pediatrics (2005) 1.11

Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc (2012) 1.09

Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. J Biol Chem (2013) 1.07

Isolated small bowel transplantation for tufting enteropathy. J Pediatr Gastroenterol Nutr (2003) 1.07

Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma. J Gastrointest Surg (2015) 1.07

Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery (2007) 1.07

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol (2012) 1.06

Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: a new association. Pediatr Transplant (2006) 1.02

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02

Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02

Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant (2006) 1.00

MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology (2002) 1.00

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99

Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99

Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc (2012) 0.98

Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg (2010) 0.98

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol (2005) 0.97

Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant (2003) 0.97

Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr (2006) 0.96

Recommendations for the Critical Care Management of Devastating Brain Injury: Prognostication, Psychosocial, and Ethical Management : A Position Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocrit Care (2015) 0.94

Evaluation of polycyclic aromatic hydrocarbons using analytical methods, toxicology, and risk assessment research: seafood safety after a petroleum spill as an example. Environ Health Perspect (2013) 0.94

Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg (2002) 0.94